South Africa: R4mn boost for Aids vaccine initiative

The South African Aids Vaccine Initiative (Saavi) has confirmed that Impala Platinum Holdings has committed R2,5mn over five years while Transnet donated R1,5mn towards their HIV/Aids vaccine research, reports the Mail and Guardian. Saavi, indicating that the funds will be used to cover research to develop new test vaccines and run clinical tests, welcomed the funding and encouraged more support and partnerships of this nature.